CompoundList
Sign in
Molecular formula

C26H30N6O4

26 compounds have this formula on CompoundList.

Molar mass
490.56g/mol
Monoisotopic mass
490.2329Da
Atoms
66
Elements
4
Rings plus double bonds
15

The formula C26H30N6O4 describes a molecule made of 26 carbon atoms, 30 hydrogen atoms, 6 nitrogen atoms and 4 oxygen atoms. It is written in Hill notation: carbon first, then hydrogen, then the other elements in alphabetical order. The formula tells you which atoms are present, not how they are connected, which is why several different chemicals can share it.

Elemental composition

  • C Carbon × 2663.66%
    12.011 × 26 = 312.286 g/mol
  • H Hydrogen × 306.16%
    1.008 × 30 = 30.240 g/mol
  • N Nitrogen × 617.13%
    14.007 × 6 = 84.042 g/mol
  • O Oxygen × 413.05%
    15.999 × 4 = 63.996 g/mol
Look up another formula

Compounds with the formula C26H30N6O4

Isomers we list, best known first. Open one to see its structure, properties, safety data and suppliers.

Showing 1 to 26 of 26 compounds

8-[[4-(Furan-2-carbonyl)piperazin-1-yl]methyl]-1,3-dimethyl-7-(3-phenylpropyl)purine-2,6-dione chemical structure, C26H30N6O4, CAS 851943-22-1
8-[[4-(Furan-2-carbonyl)piperazin-1-yl]methyl]-1,3-dimethyl-7-(3-phenylpropyl)purine-2,6-dione
CAS 851943-22-1C26H30N6O4
Ethyl 4-((1,3-dimethyl-7-(naphthalen-1-ylmethyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)methyl)piperazine-1-carboxylate chemical structure, C26H30N6O4, CAS 851939-88-3
Ethyl 4-((1,3-dimethyl-7-(naphthalen-1-ylmethyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)methyl)piperazine-1-carboxylate
CAS 851939-88-3C26H30N6O4
7-(2-Hydroxy-3-(o-tolyloxy)propyl)-3-methyl-8-(4-phenylpiperazin-1-yl)-1H-purine-2,6(3H,7H)-dione chemical structure, C26H30N6O4, CAS 536719-23-0
7-(2-Hydroxy-3-(o-tolyloxy)propyl)-3-methyl-8-(4-phenylpiperazin-1-yl)-1H-purine-2,6(3H,7H)-dione
CAS 536719-23-0C26H30N6O4
2-(2-((2,4-Dimethylphenyl)amino)-2-oxoethyl)-N-isopropyl-1,5-dioxo-4-propyl-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide chemical structure, C26H30N6O4, CAS 1105230-57-6
2-(2-((2,4-Dimethylphenyl)amino)-2-oxoethyl)-N-isopropyl-1,5-dioxo-4-propyl-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
CAS 1105230-57-6C26H30N6O4
2-[2-(Benzylamino)-2-oxoethyl]-N-isobutyl-4-isopropyl-1,5-dioxo-1,2,4,5-tetrahydro[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide chemical structure, C26H30N6O4, CAS 1105214-16-1
2-[2-(Benzylamino)-2-oxoethyl]-N-isobutyl-4-isopropyl-1,5-dioxo-1,2,4,5-tetrahydro[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
CAS 1105214-16-1C26H30N6O4
4-Benzyl-2-(2-(tert-butylamino)-2-oxoethyl)-N-isopropyl-1,5-dioxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide chemical structure, C26H30N6O4, CAS 1105230-81-6
4-Benzyl-2-(2-(tert-butylamino)-2-oxoethyl)-N-isopropyl-1,5-dioxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
CAS 1105230-81-6C26H30N6O4
4-Benzyl-2-(2-(sec-butylamino)-2-oxoethyl)-N-isopropyl-1,5-dioxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide chemical structure, C26H30N6O4, CAS 1105230-73-6
4-Benzyl-2-(2-(sec-butylamino)-2-oxoethyl)-N-isopropyl-1,5-dioxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
CAS 1105230-73-6C26H30N6O4
N-(sec-Butyl)-2-(2-((4-isopropylphenyl)amino)-2-oxoethyl)-4-methyl-1,5-dioxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide chemical structure, C26H30N6O4, CAS 1206999-42-9
N-(sec-Butyl)-2-(2-((4-isopropylphenyl)amino)-2-oxoethyl)-4-methyl-1,5-dioxo-1,2,4,5-tetrahydro-[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
CAS 1206999-42-9C26H30N6O4
2-{2-[(3-Ethylphenyl)amino]-2-oxoethyl}-N-isopropyl-1,5-dioxo-4-propyl-1,2,4,5-tetrahydro[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide chemical structure, C26H30N6O4, CAS 1242894-44-5
2-{2-[(3-Ethylphenyl)amino]-2-oxoethyl}-N-isopropyl-1,5-dioxo-4-propyl-1,2,4,5-tetrahydro[1,2,4]triazolo[4,3-a]quinazoline-8-carboxamide
CAS 1242894-44-5C26H30N6O4
N-Acetyl-L-phenylalanyl-L-phenylalanyl-L-histidinamide chemical structure, C26H30N6O4, CAS 62087-98-3
N-Acetyl-L-phenylalanyl-L-phenylalanyl-L-histidinamide
CAS 62087-98-3C26H30N6O4
(4E)-4-[[2-(4-Benzoylpiperazin-1-yl)ethylamino]methylidene]-2-(4-nitrophenyl)-5-propylpyrazol-3-one chemical structure, C26H30N6O4, CAS 371955-38-3
(4E)-4-[[2-(4-Benzoylpiperazin-1-yl)ethylamino]methylidene]-2-(4-nitrophenyl)-5-propylpyrazol-3-one
CAS 371955-38-3C26H30N6O4
7-[(2,5-Dimethylphenyl)methyl]-8-{[4-(furan-2-carbonyl)piperazin-1-yl]methyl}-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione chemical structure, C26H30N6O4, CAS 851939-13-4
7-[(2,5-Dimethylphenyl)methyl]-8-{[4-(furan-2-carbonyl)piperazin-1-yl]methyl}-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione
CAS 851939-13-4C26H30N6O4
8-(4-Benzylpiperazin-1-yl)-7-(2-hydroxy-3-phenoxypropyl)-3-methyl-1H-purine-2,6(3H,7H)-dione chemical structure, C26H30N6O4, CAS 887200-41-1
8-(4-Benzylpiperazin-1-yl)-7-(2-hydroxy-3-phenoxypropyl)-3-methyl-1H-purine-2,6(3H,7H)-dione
CAS 887200-41-1C26H30N6O4
CDK7 ligand 2 chemical structure, C26H30N6O4, CAS 2603381-71-9
CDK7 ligand 2
CAS 2603381-71-9C26H30N6O4
N-(Butan-2-yl)-3-(1,5-dioxo-2-{[(2-phenylethyl)carbamoyl]methyl}-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)propanamide chemical structure, C26H30N6O4, CAS 1243033-31-9
N-(Butan-2-yl)-3-(1,5-dioxo-2-{[(2-phenylethyl)carbamoyl]methyl}-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)propanamide
CAS 1243033-31-9C26H30N6O4
N-(Butan-2-yl)-3-[2-({[(4-methylphenyl)methyl]carbamoyl}methyl)-1,5-dioxo-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl]propanamide chemical structure, C26H30N6O4, CAS 1242891-55-9
N-(Butan-2-yl)-3-[2-({[(4-methylphenyl)methyl]carbamoyl}methyl)-1,5-dioxo-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl]propanamide
CAS 1242891-55-9C26H30N6O4
3-(1,5-Dioxo-2-{[(2,4,6-trimethylphenyl)carbamoyl]methyl}-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)-N-(propan-2-yl)propanamide chemical structure, C26H30N6O4, CAS 1112434-25-9
3-(1,5-Dioxo-2-{[(2,4,6-trimethylphenyl)carbamoyl]methyl}-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)-N-(propan-2-yl)propanamide
CAS 1112434-25-9C26H30N6O4
4-[4-(4-Methylpiperazin-1-yl)-3-nitrophenyl]-2-(2-oxo-2-piperidin-1-ylethyl)phthalazin-1-one chemical structure, C26H30N6O4, CAS 674330-83-7
4-[4-(4-Methylpiperazin-1-yl)-3-nitrophenyl]-2-(2-oxo-2-piperidin-1-ylethyl)phthalazin-1-one
CAS 674330-83-7C26H30N6O4
8-(4-(4-Methoxyphenyl)piperazin-1-yl)-3-methyl-7-(3-phenoxypropyl)-1H-purine-2,6(3H,7H)-dione chemical structure, C26H30N6O4, CAS 887866-63-9
8-(4-(4-Methoxyphenyl)piperazin-1-yl)-3-methyl-7-(3-phenoxypropyl)-1H-purine-2,6(3H,7H)-dione
CAS 887866-63-9C26H30N6O4
N-(sec-Butyl)-3-(2-(2-((4-ethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)propanamide chemical structure, C26H30N6O4, CAS 1242868-19-4
N-(sec-Butyl)-3-(2-(2-((4-ethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)propanamide
CAS 1242868-19-4C26H30N6O4
N-(sec-Butyl)-3-(2-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)propanamide chemical structure, C26H30N6O4, CAS 1242914-57-3
N-(sec-Butyl)-3-(2-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)propanamide
CAS 1242914-57-3C26H30N6O4
N-(sec-Butyl)-3-(2-(2-((2,3-dimethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)propanamide chemical structure, C26H30N6O4, CAS 1242972-25-3
N-(sec-Butyl)-3-(2-(2-((2,3-dimethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)propanamide
CAS 1242972-25-3C26H30N6O4
3-(2-(2-((2,3-Dimethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)-N-isobutylpropanamide chemical structure, C26H30N6O4, CAS 1113106-46-9
3-(2-(2-((2,3-Dimethylphenyl)amino)-2-oxoethyl)-1,5-dioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinazolin-4(5H)-yl)-N-isobutylpropanamide
CAS 1113106-46-9C26H30N6O4
N-(Butan-2-yl)-3-(2-{[(2,5-dimethylphenyl)carbamoyl]methyl}-1,5-dioxo-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)propanamide chemical structure, C26H30N6O4, CAS 1242996-09-3
N-(Butan-2-yl)-3-(2-{[(2,5-dimethylphenyl)carbamoyl]methyl}-1,5-dioxo-1H,2H,4H,5H-[1,2,4]triazolo[4,3-a]quinazolin-4-yl)propanamide
CAS 1242996-09-3C26H30N6O4

Frequently asked questions

What is the molar mass of C26H30N6O4?

The molar mass of C26H30N6O4 is 490.56 g/mol, calculated from standard atomic weights for 26 carbon atoms, 30 hydrogen atoms, 6 nitrogen atoms and 4 oxygen atoms. The monoisotopic mass is 490.2329 Da.

How many compounds have the formula C26H30N6O4?

CompoundList lists 26 compounds with the molecular formula C26H30N6O4, including 8-[[4-(Furan-2-carbonyl)piperazin-1-yl]methyl]-1,3-dimethyl-7-(3-phenylpropyl)purine-2,6-dione, Ethyl 4-((1,3-dimethyl-7-(naphthalen-1-ylmethyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)methyl)piperazine-1-carboxylate, 7-(2-Hydroxy-3-(o-tolyloxy)propyl)-3-methyl-8-(4-phenylpiperazin-1-yl)-1H-purine-2,6(3H,7H)-dione. Compounds that share a formula are isomers. They contain the same atoms arranged differently, so their properties, uses and prices can be very different.

What is the degree of unsaturation of C26H30N6O4?

C26H30N6O4 has a degree of unsaturation of 15. That is the total number of rings and pi bonds (a double bond counts as one, a triple bond as two) in any structure with this formula.